Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow‐up
This study establishes a simple, pathologically derived model (pT3-4/pN+/pT2 + LVI) that effectively stratifies post-RC patients, enabling a risk-adapted FU strategy. Prospective evaluation of this framework is required to confirm its clinical utility, safety, and cost-effectiveness.
Authors
- Ronan Flippot (ORCID: https://orcid.org/0000-0003-0083-4753)
- Laura S. Mertens (ORCID: https://orcid.org/0000-0003-3317-6427)
- Francesco Soria (ORCID: https://orcid.org/0000-0001-8443-8453)
- Pietro Scilipoti (ORCID: https://orcid.org/0009-0007-6126-9889)
- Valerio Santarelli (ORCID: https://orcid.org/0009-0009-9689-438X)
- Nicola Pavan (ORCID: https://orcid.org/0000-0001-7355-7625)
- P. Desprez
- Markus von Deimling (ORCID: https://orcid.org/0000-0002-9954-3413)
- S. Perdona
- Francesco Claps
- Elena Tonin
- Gauthier Marcq
- Jeremy Y. C. Teoh
- David D’Andrea
- Angelo Porreca
- Paolo Gontero
- Renate Pichler
- Marc Furrer
- Benjamin Pradere
- Marco Moschini
- Antonio Amodeo
- Francesco Del Giudice
- Aleksander Ślusarczyk
- Andrea Mari
- Bas WG van Rhijn
- Rodolfo Hurle
- Alchiede Simonato
- Alberto Martini
- Lorenzo Bianchi
- Roberto Contieri
- José Daniel Subiela
Institutions
- University of Bern (CH)
- Centre National de la Recherche Scientifique (FR)
- Innsbruck Medical University (AT)
- Inserm (FR)
- Universität Hamburg (DE)
- Chinese University of Hong Kong (HK)
- Universidad de Alcalá (ES)
- Université de Lille (FR)
- Medical University of Warsaw (PL)
- Université Paris-Saclay (FR)
- Policlinico Umberto I (IT)
- Institut Pasteur de Lille (FR)
- University Hospital of Bern (CH)
- Institut Gustave Roussy (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Comprehensive Cancer Center Vienna (AT)
- Fondazione Ricerca Molinette (IT)
- University Medical Center Hamburg-Eppendorf (DE)
- Istituto Oncologico Veneto (IT)
- Oncode Institute (NL)
- Groupe Hospitalier Diaconesses Croix Saint-Simon (FR)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Azienda USL di Bologna (IT)
- Humanitas Gavazzeni (IT)
- Solothurner Spitäler (CH)
- IRCCS Ospedale San Raffaele (IT)
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
- Hôpital Claude Huriez (FR)
- Hospital Universitario Ramón y Cajal (ES)
- Bicêtre Hospital (FR)
- IRCCS Humanitas Research Hospital (IT)
- University of Florence (IT)
- Medical University of Vienna (AT)
- University of Palermo (IT)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1111/bju.70232
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00